SCHEMBL30201251

SCHEMBL30201251

C[C@H]1CCCN(C(=O)c2cnc3c(ccn3-c3ccc(C#N)nc3)c2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.48
RECQL P46063 1/20 0.44
GRM5 P41594 4/20 0.44
KDM1A O60341 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
VNN1 O95497 1/20 0.39
MGLL Q99685 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24942223 0.89 HPGD (0.50) HPGDRECQLGRM5KDM1AALDH1A1
SCHEMBL29257187 0.89 HPGD (0.50) HPGDRECQLGRM5KDM1AALDH1A1
SCHEMBL30201361 0.88 HPGD (0.44) HPGDKDM1AVNN1MGLLNOS1
SCHEMBL23680752 0.87 HPGD (0.63) HPGDGRM5MGLLNOS1NOS2
SCHEMBL23675222 0.85 HPGD (0.53) HPGDRECQLGRM5ALDH1A1MAPT
SCHEMBL23675221 0.85 HPGD (0.53) HPGDRECQLGRM5ALDH1A1MAPT
SCHEMBL24942775 0.85 HPGD (0.53) HPGDRECQLGRM5ALDH1A1MAPT
SCHEMBL29565241 0.85 HPGD (0.53) HPGDRECQLGRM5ALDH1A1MAPT
SCHEMBL31038243 0.85 HPGD (0.49) HPGDRECQLGRM5KDM1AALDH1A1
SCHEMBL30202246 0.84 HPGD (0.44) HPGDALDH1A1MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240294519-A1 PYRROLO[2,3-b]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING EPIRIUM BIO INC. 2024-09-05 US disclosed
CN-118338902-A Pyrrolo [2,3-b ] pyridine PGDH inhibitors and methods of making and using the same 埃皮里姆生物股份有限公司 2024-07-12 CN disclosed
EP-4376841-A1 PYRROLO[2,3-B]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING Epirium Bio Inc. (US) 2024-06-05 EP disclosed
WO-2023009642-A1 PYRROLO[2,3-B]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING EPIRIUM BIO INC. (US) 2023-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294519-A1 PYRROLO[2,3-b]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING HPGD, HPGDS, PTGIS HPGD 1/4885RECQL 696/4885GRM5 1255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.